Skip to main content

AbCellera Biologics Inc 10-K for FY2023

AbCellera Biologics Inc. (ABCL)

10-K 2024-02-20 For: 2023-12-31
View Original
Added on April 08, 2026

About this 10-K

AbCellera Biologics Inc filed this 10-K on February 20, 2024, covering the fiscal year ended December 31, 2023 (FY2023).

Headline figures

Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$38.03M
down 92.2% from $485.42M a year earlier
Net loss
$146.4M
compared with net income of $158.52M a year earlier
Diluted EPS
-$0.51
compared with $0.50 a year earlier